>
Organization
Novartis AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Novartis AG

... Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among ...
... remakes its manufacturing network as part of a $1.1 billion cost-cutting plan. RELATED:Novartis' under-pressure Sandoz unit offloads Quebec plant to fast-growing Avara This was the ...
... was a stellar year for CBMG. The licensing and collaboration agreement with Novartis reaffirmed our position in the cell therapy industry. We continue to focus ...
... PR Newswire Sandoz Inc., a Novartis division, today announced that the authorized generic of SUBOXONE® 1 (buprenorphine and ...
... As an FDA action date quickly approaches for a gene therapy that Novartis snatched up last year, the biotech that is developing the treatment says ...
... Newswire Alcon, the global leader in eye care and a division of Novartis, will debut theiLux®MGD Treatment System to the Eye Care Professional (ECP) community ...
... translocated cholangiocarcinoma is expected later this year, as is the submission, by Novartis, for the approval of capmatinib in patients with MET exon-14 skipping non-small ...
... Fisher Scientific, Merck KGaA, Merck & Co., Bristol-Myers Squibb, Cambridge Assessment English, Novartis, Incyte, Sanofi Pasteur, and Red Hat. “This remarkable group of companies has ...
... of European regulators to usher in a new age of regenerative medicine. Novartis' Kymriah was given marketing authorization in the EU for the treatment of ...
... translocated cholangiocarcinoma is expected later this year, as is the submission, by Novartis, for the approval of capmatinib in patients with MET exon-14 skipping non-small ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/novartis-ag-o258830
  • https://relationshipscience.com/News/novartis-ag-o258830
Subscribe now for full coverage on Novartis AG
Start My Free Trial